Discovery of an insulin‐induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element‐binding protein–mediated lipogenesis
Shi‐You Jiang(Kunming Institute of Botany), Wei Qi(Jilin University), Bao‐Liang Song(Shandong Tumor Hospital), Xinglin Yang(Indiana University School of Medicine), Huili Hu(Beijing Children’s Hospital), Juewan Li(ShanghaiTech University), Xin‐Yuan Meng(Shandong University), Liguo Wang(Beijing Tongren Hospital), Meng‐Qiang Xu(ShanghaiTech University), Yu-Xiu Qu(ShanghaiTech University), Yu Rao(Soochow University), Yun‐Feng Li(Wuhan University), Jingjie Tang(Center for Excellence in Molecular Cell Science), Zimo Yang(University of Electronic Science and Technology of China)
Cited by 58
Related Papers
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
|Cell Research|2018|280
Chemistries of bifunctional PROTAC degraders
|Chemical Society Reviews|2022|270